Chronic kidney disease and diabetes

R Pyram, A Kansara, MA Banerji, L Loney-Hutchinson - Maturitas, 2012 - Elsevier
Chronic kidney disease has a significant worldwide prevalence affecting 7.2% of the global
adult population with the number dramatically increasing in the elderly. Although the causes …

[HTML][HTML] A promising choice in hypertension treatment: Fixed-dose combinations

X Wan, P Ma, X Zhang - asian journal of pharmaceutical sciences, 2014 - Elsevier
Obtaining the target blood pressure level by monotherapy can be challenging currently,
especially for the patients who are suffering from other diseases meanwhile. It is …

Cocrystal of apixaban–quercetin: Improving solubility and bioavailability of drug combination of two poorly soluble drugs

L Zhang, D Kong, H Wang, L Jiao, X Zhao, J Song… - Molecules, 2021 - mdpi.com
Drug combinations have been the hotspot of the pharmaceutical industry, but the promising
applications are limited by the unmet solubility and low bioavailability. In this work, novel …

State-of-the-art treatment of hypertension: established and new drugs

M Burnier, Y Vuignier, G Wuerzner - European heart journal, 2014 - academic.oup.com
The treatment of essential hypertension is based essentially on the prescription of four major
classes of antihypertensive drugs, ie blockers of the renin–angiotensin system, calcium …

Renal protection with calcium antagonists: the role of lercanidipine

M Burnier - Current medical research and opinion, 2013 - Taylor & Francis
Background: Clinical research in the field of hypertension is now increasingly focusing on
the potential effects of antihypertensive treatments that may go beyond the reduction of …

Can lercanidipine improve renal function in patients with atherosclerotic renal artery stenosis undergoing renal artery intervention?

M Peng, X Jiang, H Dong, Y Zou, H Zhang… - Current Medical …, 2015 - Taylor & Francis
Objective: To investigate the renal-protective effect of lercanidipine in patients undergoing
renal artery intervention. Methods: A prospective, single-center, cohort study was conducted …

ИАПФ при ХСН: обоснованность терапии при смене ее целей

АГ Арутюнов - Трудный пациент, 2014 - cyberleninka.ru
Декомпенсация кровообращения является одним из наиболее жизнеугрожающих
состояний у пациента с хронической сердечной недостаточностью. Каждая …

Emerging drug combinations to optimize renovascular protection and blood pressure goals

C Escobar, R Echarri, V Barrios - International journal of …, 2012 - Taylor & Francis
Hypertension and renal disease are closely related. In fact, there is an inverse linear
relationship between renal function and prevalence of hypertension. Hypertensive patients …

Polypharmacology in Clinical Applications: Renal Polypharmacology

Z Wang, B Yang - Polypharmacology: Principles and Methodologies, 2022 - Springer
The urinary system, also known as the renal system or urinary tract, consists of the kidneys,
ureters, bladder, and the urethra. The purpose of the urinary system is to eliminate waste …

Gipotenzivnaya terapiya: novaya kombinatsiya i novye vozmozhnosti

EA Prokhorovich - Consilium Medicum, 2013 - journals.eco-vector.com
При выборе гипотензивной терапии для конкретного пациента врач оценивает не
только эффективность (способность снижать АД и возможность органопротекции), но и …